Misrepresentation of statin safety evidence
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several factors including female sex, ethnicity, multisystem disease, and small body frame predispose to SAMS (see Box 1), with the presence of an increasing number of factors associated with greater risk.9,30,32–34”
Citations
Cites
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
Crouse, J. R., Raichlen, J. S., Riley, W. A., Evans, G. W., Palmer, M. K., O’Leary, D. H., Grobbee, D. E., Bots, M. L., & METEOR Study Group, F. T. (2007) · JAMA · doi:10.1001/jama.297.12.1344 · Cited by 708
Concerns about the latest NICE draft guidance on statins
McPherson, K. (2014) · BMJ · doi:10.1136/bmj.g4130 · Cited by 13
Cited by
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857
“Consequently, even though different randomized trials of statin therapy did not always use the same methods to identify or classify muscle symptoms (and may even have failed to detect some relevant events: see Table 1), each within-trial blinded comparison should still provide a reliable assessment of the effects of s…”
BackgroundSelf-citationStroes, E. S., Thompson, P. D., Corsini, A., Vladutiu, G. D., Raal, F. J., Ray, K. K., Roden, M., Stein, E., Tokgözoğlu, L., Nordestgaard, B. G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv043 · Cited by 1,443
Invited debate: NHS Health Checks--a naked emperor?
Capewell, S., McCartney, M., & Holland, W. (2015) · Journal of Public Health · doi:10.1093/pubmed/fdv063 · Cited by 65
Livingstone, S. J., Looker, H. C., Akbar, T., Betteridge, D. J., Durrington, P. N., Hitman, G. A., Neil, H. A. W., Fuller, J., & Colhoun, H. M. (2015) · Diabetologia · doi:10.1007/s00125-015-3802-6 · Cited by 53
Statin tolerability: In defence of placebo-controlled trials
Tobert, J. A., & Newman, C. B. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487315602861 · Cited by 42
“Association is not causation and an adverse event is not necessarily an adverse effect,(20,21) but this is sometimes forgotten.(22) A recent large and carefully conducted cohort study(23) has provided valuable information on withdrawal from statins, including the fact that statin therapy could be restored in 92% of th…”
Background
Metadata
- Authors
- Armitage, J., Baigent, C., & Collins, R.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Collins, Rory
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 384
- Issue
- 9950
- Pages
- 1263-1264
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2019669663
- Cited by
- 10
- References
- 5
- Citations by year
- 2016: 3 · 2015: 7
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Keywords
- statins, statin safety, NICE guidelines, media coverage, public health communication, cardiovascular risk
- MeSH terms
- Humans, Randomized Controlled Trials as Topic, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Evidence-Based Medicine, Professional Misconduct
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Misrepresentation of statin safety evidence. https://app.cochat.ai/papers/10.1016/s0140-6736(14)61765-7
- The paper
- Armitage, J., Baigent, C., & Collins, R. (2014). Misrepresentation of statin safety evidence. The Lancet. https://doi.org/10.1016/s0140-6736(14)61765-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.